Octagon Capital Advisors
Overview
Octagon Capital Advisors is a hedge fund manager that invests in public and private healthcare companies globally.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Beijing Safe Pharmaceutical Technology Co., Ltd. | Feb 2021 | IPO | Co-investor |
| Abogen Biosciences | Aug 2021 | Series C | Co-investor |
| Numab Therapeutics | Jan 2025 | Series C Extension | Co-investor |
| Shanghai Hanyu Medical Technology | Mar 2021 | Series D Extension | Co-investor |
| Aktis Oncology | Aug 2022 | Series A Extension | Co-investor |
For institutional investors. Book with your work email.
Key People
Ting Jia
Founder
JianQing Li
Member Board Of Directors
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Octagon Capital Advisors based?
Octagon Capital Advisors is headquartered in New York City, New York, United States.
When was Octagon Capital Advisors founded?
Octagon Capital Advisors was founded in 2019.
How many portfolio companies does Octagon Capital Advisors have?
Octagon Capital Advisors has 21 portfolio companies in Caplight's dataset.
What are some companies in Octagon Capital Advisors's portfolio?
Portfolio companies visible on Caplight include Beijing Safe Pharmaceutical Technology Co., Ltd., Abogen Biosciences, Numab Therapeutics, Shanghai Hanyu Medical Technology, Aktis Oncology.
What was Octagon Capital Advisors's most recent investment shown here?
Octagon Capital Advisors's most recent investment in this portfolio sample was in Numab Therapeutics in 2025.
What sectors does Octagon Capital Advisors focus on?
Octagon Capital Advisors focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Enterprise Software, Frontier & Industrial Tech.
What company stages does Octagon Capital Advisors focus on?
Octagon Capital Advisors typically invests at the Mid stage.
What is Octagon Capital Advisors's AUM?
Octagon Capital Advisors's assets under management are estimated between $919.8M and $1.1B.